Analysts’ View: Shake Shack (SHAK), BioLineRx (BLRX), Telefonica S.A. (TEF)

Investment Analysts at Wedbush upgraded Shake Shack Inc. (NYSE:SHAK) shares from Neutral to Outperform rating while increasing their price target from $33 to $43.

Shake Shack Inc. owns, operates, and licenses Shake Shack restaurants (Shacks) in the United States and internationally.


Brokerage Firm Maxim Group upgraded BioLine Rx Ltd (NASDAQ:BLRX) shares from Hold to Buy rating while increasing their price target from $1 to $3.

BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs.


Telefónica, S.A. (NYSE:TEF) shares were upgraded by analysts at Goldman from Neutral to Buy rating.

Telefónica, S.A. provides mobile and fixed communication services primarily in the European Union and Latin America.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at